Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024

Tomas Kauer - Moderator

Sep 9, 2024 - 14:00

Innate Pharma SA: Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024

Tags:

Previous Article

BW LPG Limited “ Ex dividend USD 0.58 on the Oslo Stock Exchange today

Dollar steadies, yen slips as traders grapple with Fed rate-cut outlook

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

5 big analyst AI moves: AI stocks not in bubble; SMCI downgraded

5 big analyst AI moves: AI stocks not in bubble; SMCI d...

Tomas Kauer - Mode... Sep 8, 2024

Flooding in Thailand maroons thousands in northern province

Flooding in Thailand maroons thousands in northern prov...

Tomas Kauer - Mode... Sep 12, 2024

Analysis-Will Taylor Swift's Harris endorsement influence the U.S. election?

Analysis-Will Taylor Swift's Harris endorsement influen...

Tomas Kauer - Mode... Sep 14, 2024